CMPI

cCAM Biotherapeutics

The company develops monoclonal antibody immunotherapies to treat cancer patients with advanced or recurrent malignancies.

Replimune Group

The company develops oncolytic immunotherapies for cancer patients, including its first commercial treatment for adults with advanced melanoma.

IO Biotech

The company develops immune-modulating therapeutic cancer vaccines to treat patients with melanoma and other solid tumours.

Replimune

Replimune develops oncolytic immunotherapies for cancer patients, including an approved viral treatment for adults with advanced, treatment-resistant melanoma.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

Cytovation

This company develops synthetic peptide immunotherapies to treat patients with solid tumours by targeting cancer cell membranes and stimulating immune responses.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.